Metropolitan Life Insurance Company (MetLife)’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,507
Closed -$220K 1372
2024
Q1
$220K Sell
3,507
-241
-6% -$13.6K 0.01% 677
2023
Q4
$209K Sell
3,748
-4
-0.1% -$212 0.01% 711
2023
Q3
$193K Buy
3,752
+135
+4% +$7.06K 0.01% 695
2023
Q2
$190K Buy
3,617
+77
+2% +$3.97K 0.01% 699
2023
Q1
$183K Sell
3,540
-447
-11% -$24.4K 0.01% 708
2022
Q4
$208K Buy
3,987
+83
+2% +$4.55K 0.01% 696
2022
Q3
$221K Sell
3,904
-829
-18% -$52.2K 0.01% 646
2022
Q2
$287K Sell
4,733
-653
-12% -$37.2K 0.01% 587
2022
Q1
$318K Sell
5,386
-8,996
-63% -$512K 0.01% 627
2021
Q4
$827K Sell
14,382
-290
-2% -$16K 0.01% 1106
2021
Q3
$785K Sell
14,672
-831
-5% -$51.9K 0.01% 1139
2021
Q2
$1.04M Sell
15,503
-916
-6% -$63.9K 0.01% 980
2021
Q1
$1.19M Sell
16,419
-1,341
-8% -$93.6K 0.02% 828
2020
Q4
$1.23M Sell
17,760
-42
-0.2% -$2.67K 0.02% 751
2020
Q3
$1.07M Sell
17,802
-945
-5% -$58.3K 0.02% 700
2020
Q2
$1.14M Buy
18,747
+2,267
+14% +$125K 0.02% 661
2020
Q1
$816K Sell
16,480
-418
-2% -$31.7K 0.02% 788
2019
Q4
$1.38M Buy
16,898
+1,321
+8% +$108K 0.02% 736
2019
Q3
$1.28M Buy
15,577
+429
+3% +$34.9K 0.02% 728
2019
Q2
$1.18M Buy
15,148
+204
+1% +$15.9K 0.02% 806
2019
Q1
$1.17M Sell
14,944
-183
-1% -$14.5K 0.02% 798
2018
Q4
$1.14M Buy
15,127
+53
+0.4% +$3.99K 0.02% 731
2018
Q3
$1.14M Buy
15,074
+83
+0.6% +$6.34K 0.02% 864
2018
Q2
$1.1M Sell
14,991
-3
-0% -$212 0.02% 870
2018
Q1
$1.01M Buy
14,994
+281
+2% +$19.2K 0.01% 895
2017
Q4
$1.11M Sell
14,713
-14,243
-49% -$1.11M 0.01% 838
2017
Q3
$2.24M Sell
28,956
-185
-0.6% -$14.5K 0.01% 904
2017
Q2
$2.31M Buy
29,141
+1,691
+6% +$128K 0.02% 902
2017
Q1
$1.99M Sell
27,450
-228
-0.8% -$16.7K 0.01% 959
2016
Q4
$2.05M Sell
27,678
-271
-1% -$19.9K 0.01% 962
2016
Q3
$2.19M Sell
27,949
-186
-0.7% -$14.6K 0.02% 921
2016
Q2
$2.11M Sell
28,135
-58
-0.2% -$4.03K 0.02% 917
2016
Q1
$1.88M Buy
28,193
+193
+0.7% +$11.9K 0.01% 916
2015
Q4
$1.7M Buy
28,000
+790
+3% +$47.1K 0.01% 955
2015
Q3
$1.56M Sell
27,210
-1,782
-6% -$108K 0.01% 1010
2015
Q2
$1.81M Sell
28,992
-3,950
-12% -$264K 0.01% 1004
2015
Q1
$2.34M Sell
32,942
-13
-0% -$938 0.02% 845
2014
Q4
$2.31M Buy
32,955
+2,246
+7% +$146K 0.02% 923
2014
Q3
$1.75M Sell
30,709
-192
-0.6% -$11.9K 0.01% 996
2014
Q2
$1.93M Buy
30,901
+2,002
+7% +$123K 0.01% 1015
2014
Q1
$1.75M Buy
28,899
+160
+0.6% +$9.7K 0.01% 1043
2013
Q4
$1.61M Buy
28,739
+3,835
+15% +$228K 0.01% 1072
2013
Q3
$1.42M Sell
24,904
-23
-0.1% -$1.37K 0.01% 1109
2013
Q2
$1.49M Buy
+24,927
New +$1.61M 0.01% 1033

Other funds holding NHI

Metropolitan Life Insurance Company (MetLife)'s NHI Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of National Health Investors (NHI) in Q2 2024, closing a stake of 3,507 shares — an estimated $220K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NHI in Q2 2013 and held it in 44 quarters. The position peaked at $2.34M in Q1 2015. 231 funds tracked by Wall St. Rank hold NHI as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining National Health Investors position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,507 National Health Investors shares in Q2 2024, an estimated $220K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in National Health Investors in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s National Health Investors position peaked at $2.34M in Q1 2015.
  • 231 funds tracked by Wall St. Rank held National Health Investors as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.